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Background: Successful recruitment of participants to any trial is central to its success. Trial results are routinely
published, and recruitment is often cited to be slower and more difficult than anticipated. This article reflects on
the methodological challenges of recruiting women with prolapse attending United Kingdom (UK) gynaecology
outpatient clinics to a multi-centre randomised controlled trial (RCT) of physiotherapy, and the systems put in place
in an attempt to address them.
Methods: Gynaecology outpatients with symptomatic prolapse were to be recruited over a 16-month period from
14 UK hospitals and one New Zealand hospital. Eligible women were informed about the trial by their gynaecologist
and informed consent was obtained by the central trial office. Recruitment difficulties were encountered early on, and a
number of strategies were employed to try to improve recruitment.
Results: Some strategies were more successful than others and they differed in the resources required. Actions that
facilitated recruitment included increasing recruiting centres to 23 UK and two international hospitals, good centre
support, using processes embedded in clinical practice, and good communication between the trial office, collaborators
and participants. Collaborator incentives, whereby staff involved received the benefit immediately, were more successful
than a nominal monetary payment per woman randomised. Barriers to recruitment included fewer eligible women than
anticipated, patient’s preference to receive active treatment rather than allocation to the control group, lack of support
staff and high staff turnover. Geographical variations in Primary Care Trust Research Management and Governance
approval systems and general practitioner (GP) referral procedures also impacted negatively on recruitment.
Conclusions: Our article reflects on the methodological challenges of recruiting to a multi-centre RCT in a UK
gynaecology setting. Effective interventions included increasing the number of recruiting centres and providing
collaborator incentives. Barriers to recruitment included fewer eligible women than anticipated, patient’s preference to
be allocated to the treatment group, lack of support staff, and variations in approval systems and GP referral procedures.
To improve the evidence base on clinical trial recruitment, trialists need to publish their experiences and lessons learned.
Future RCTs should evaluate, where possible, the effect of strategies designed to improve recruitment and retention.
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Keywords: Randomised controlled trial, Recruitment, Barriers, Gynaecology* Correspondence: sylvia.dickson@gcu.ac.uk
1Nursing, Midwifery and Allied Health Professions Research Unit, Glasgow
Caledonian University, Buchanan House, Cowcaddens Road, Glasgow G4
0BA, UK
Full list of author information is available at the end of the article
© 2013 Dickson et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the orl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Dickson et al. Trials 2013, 14:389 Page 2 of 8
http://www.trialsjournal.com/content/14/1/389Background
Randomised Controlled Trials (RCTs) are considered to
be the gold standard for evaluating healthcare inter-
ventions. Key to the success of any RCT is successful
recruitment of participants. Less than one-third of publi-
cally funded trials manage to recruit their original target
within the time originally specified and around one-
third request additional funding and/or time [1]. There-
fore, it is not surprising that more research papers (for
example, [2-5]) are reporting on the many challenges of
managing recruitment to RCTs and strategies to over-
come them.
The POPPY (Pelvic Organ Prolapse PhysiotherapY)
Trial was a multi-centre RCT which assessed the effective-
ness and cost-effectiveness of individualised pelvic floor
muscle training (PFMT) compared to a lifestyle advice leaf-
let for women with symptomatic pelvic organ prolapse.
The main findings of this trial are published elsewhere [6].
This article describes the methodological challenges of
recruiting to a multi-centre RCT of a complex intervention
in a gynaecology setting, and the methods we used in an
attempt to address them. These experiences and solutions
may prove helpful for other large trials.
Methods
The aim of the trial was to recruit 520 new gynaecology
outpatients with symptomatic prolapse over a 16-month
period from 14 UK hospitals and one New Zealand hos-
pital. All the trial processes and documentation were
approved by the relevant Ethics and Research and Devel-
opment Committees and women gave signed informed
consent to being randomised and to participate in long-
term follow-up. Women were randomised by trial office
staff using a central internet-based randomisation system
to receive either PFMT (delivered by a physiotherapist
who assessed and treated them at five appointments over
16 weeks and who prescribed a daily exercise programme),
or to receive a Lifestyle Advice Sheet by post. The trial
was overseen by an independent Trial Steering Committee
(TSC) and a separate, independent Data Monitoring and
Ethics Committee (DMEC).
We based our expected recruitment rate on data from
our feasibility study (a pilot trial in two centres, com-
pleted in August 2005) [7]. Based on this informa-
tion, we predicted that in a typical recruiting centre,
at least three women per month would agree to be
randomised, which would give 36 randomised women
per centre over a 12-month recruitment period. How-
ever, in the main trial we encountered recruitment
problems due to fewer eligible women presenting to par-
ticipating clinics than predicted and women’s preference
to receive active treatment such as pelvic floor muscle
training, vaginal pessary (a device inserted vaginally to
support the prolapse) or surgery. As a result of this lowerrecruitment rate, we explored a number of avenues in an
attempt to improve recruitment and reach our recruit-
ment target.
Results
Recruitment of participants
Gynaecologists completed a trial entry form for all new
outpatient referrals to gynaecology if the referral letter
indicated that the woman had prolapse symptoms. Infor-
mation from the completed entry form indicated whether
a woman was eligible for inclusion or not. The gynaecolo-
gist, or another nominated member of staff, then discussed
trial participation with eligible women and provided them
with a Patient Information Leaflet.
On receipt of the completed trial entry form a mem-
ber of the research team from the central trial office
contacted willing and eligible participants by tele-
phone to seek their informed consent to trial partici-
pation. Following verbal consent, women were sent a
consent form and baseline questionnaire to complete
at home. Women were allowed three weeks to return
their completed consent form and baseline question-
naire before being given a reminder telephone call. In
total there were 146 baseline reminder telephone calls
made; 68 women were contacted, and 72% went on to
be randomised. Of the 78 who were not successfully
contacted by telephone, a reminder letter and second
copy of the baseline paperwork was sent. Forty-six
percent of these women then went on to be rando-
mised. The gynaecologists assessed prolapse staging
using the Pelvic Organ Prolapse-Quantification system
(POP-Q) [8] before randomisation and at 6 months post-
randomisation. Women completed postal questionnaires
at 6 and 12 months after randomisation, and a 24-month
follow-up postal questionnaire was sent to a smaller num-
ber of women who consented to longer term follow-up
(Table 1).
Facilitators to recruitment
Trial extension
After 15 months of recruitment, when 175 women had
been randomised, a request for additional funding and
time was made to the funders to increase the duration
of recruitment at existing centres by 12 months and to
recruit additional centres. This extension was granted in
February 2009 and allowed nine new UK centres and
one extra international centre to come on board and re-
cruit to the trial. Ultimately, 23 UK centres and two
international centres (one in New Zealand and one in
Australia, both of which were funded separately from
the UK centres) recruited to the trial over a 30-month
period. We finally randomised 448 women, of which one
woman withdrew consent to using any of her data, leav-
ing 447 (Figure 1).
Table 1 Recruitment success by centre
Centre
number
Total
randomised
Recruitment
period
(months)
Geographic
location
Local
researcher
(Y/N)
a1 130 30 Scotland Y
2 0 23 Northern Ireland N
3 12 27 Scotland Y
4 0 0 England Y
5 37 28 Scotland Y
6 3 20 Scotland Y
7 20 29 Scotland Y
8 30 23 Scotland Y
9 33 13 England Y
10 6 27 Scotland N
11 6 27 Scotland Y
a12 38 30 Scotland Y
13 1 28 Scotland N
14 5 23 England N
15 28 29 Scotland N
16 0 30 Scotland N
c17 19 33 New Zealand Y
18 0 30 Scotland N
19 7 22 England N
b20 8 9 England Y
b21 2 12 England Y
b22 6 11 England Y
b23 14 14 England N
b24 7 13 England Y
b25 6 13 England Y
b26 3 12 England Y
b27 0 9 England N
b28 3 9 England Y
b29 2 13 Northern Ireland N
b,c30 22 24 Sydney N
aPilot centres. Recruitment numbers do not include women from the pilot
study. bNew centre recruited as a result of trial extension. cThese centres were
funded and managed separately from the UK centres, and recruitment started
earlier in the New Zealand centre. Recruitment never started in centres 2, 4,
16, 18 and 27.
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The POPPY trial brought together a multidisciplinary
group of hospital staff including gynaecologists, physio-
therapists, nurses, secretaries and medical records. To
ensure the trial was delivered according to the protocol
and that accurate data were collected, it was important
that everyone involved felt confident about the aims of
the research and were adequately trained in the trial
processes and procedures. Every UK centre had a site
initiation visit from the trial team, bringing the relevantstaff members together to fully describe the trial and the
different roles and responsibilities of the local team
members, to provide all trial materials and to confirm
local trial arrangements. Subsequent visits were offered
when necessary, and as a result, six centres had a second
visit to further assist their participation in the trial.
Many of the trial processes were embedded in existing
clinical practice. For example, the POP-Q assessment
method was already used by some gynaecologists when
recording prolapse type and severity, and PFMT was an
intervention routinely delivered by the majority of physio-
therapists involved for women with urinary incontinence.
Therefore, some components of the trial were familiar to
the clinical collaborators, an important contributory factor
in a successful trial [1].
Minimising centre workload
Inevitably, RCTs generate extra work, both clinical and
administrative, for centres involved. In order to minim-
ise this burden, where possible we employed a dedicated
local researcher (for example, a local nurse, physiother-
apist or secretary with dedicated trial time) at participat-
ing centres to support recruitment and trial delivery
more generally. The local researcher was able to facili-
tate the recruitment process by screening notes prior to
clinics and attaching a data collection form to those of
potentially eligible women for completion by the gynae-
cologist during clinic appointments. Having a dedicated
person to aid recruitment in this way was helpful for
both the recruiting gynaecologist and the trial office. For
the recruiting gynaecologist it meant potentially eligible
women were already highlighted to them indicating pos-
sible participation in the trial should be discussed with
the woman, saving them time during busy clinics. For
the trial office, having a local researcher meant there
was access to a person at the centre who had dedicated
time to assist with recruitment and who could be con-
tacted directly to discuss problems.
We also, wherever possible, adapted the trial processes
to fit in with existing local practice. This included inter-
cepting clinical notes, as described above, having Patient
Information Leaflets readily available in all recruiting
clinics and displaying recruitment posters in both clinic
and waiting room areas.
Involvement of general practitioners
Following discussions with recruiting gynaecologists and
local researchers, it became evident that many women
were being referred from their general practitioner (GP)
with a clear idea of what treatment they wanted to receive
for their prolapse symptoms (for example, insertion of a
vaginal pessary or prolapse repair surgery), making them
less likely to consider participation in the trial. It was
hypothesised that if women were counselled by their GP,
2,093 trial entry forms completed
603 women eligible for POPPY RCT
448 women randomised to POPPY RCT
225 Intervention 223 Control
1 Control 
woman 
withdrew 
consent to 
use data
[1,490 not eligible]
[90 withdrew pre-randomisation and 
65 were lost to follow-up]
Figure 1 Overview of recruitment.
Dickson et al. Trials 2013, 14:389 Page 4 of 8
http://www.trialsjournal.com/content/14/1/389who is generally their first point of contact, that the
POPPY trial was another treatment option available at
their hospital, then recruitment might improve. Thus in-
volvement was sought from GP practices in areas feeding
into trial centres.
In conjunction with the Scottish [9] and English [10]
Primary Care Research Networks (PCRNs), we aimed to
inform appropriate GPs (those who would normally refer
to participating trial centres) of the trial. For example, if
a GP suspected prolapse and the decision was to refer
for a gynaecology outpatient appointment, the GP could
address the referral letter to a recruiting gynaecologist.
The GP would then inform the woman that the trial was
available, and if she was eligible, the gynaecologist would
discuss participation with her.
In order to do this, the trial had to be adopted by the
Scottish and English PCRNs, and approvals from both
Ethical and Research and Development for each partici-
pating centre were required. In reality, this was a very
time-consuming process and was introduced too late to
be of benefit. The trial started in April 2007 and stopped
at the end of March 2011, including the 12-month ex-
tension. In Scotland, initial contact was made with the
SPCRN in September 2008, 12 months after recruitment
started, and agreement to the involvement of GPs was
granted in April 2009. The approvals and set-up pro-
cesses then took another four months, with GPs being
sent information about the trial in August 2009, seven
months before the end of recruitment.
In England, the process was more complex. Initial
adoption by the network was relatively easy and quick,
with our application for adoption being approved in June
2009, one month after submission. However, in addition
to securing local Research and Development approval
appropriate Primary Care Trust Research Management
and Governance (PCT RM&G) approval had to be gained
separately for each relevant geographical area. Applicationsfor RM&G approvals were initiated in August 2009. In
October 2009 we were informed we needed to secure
service support costs to compensate GPs for their time
to review the GP information leaflet and discuss the trial
with prospective participants. It had been previously indi-
cated in July 2009 that as the GP role was minimal it did
not incur service support costs. This decision consequently
delayed the approvals process whilst support costs were
calculated and applications for funding were made. A deci-
sion was taken by the research team in November 2009
not to pursue further applications for PCT RM&G ap-
provals and focus on the three centres for which approvals
and support costs were in place.
Barriers to recruitment
Recruitment proved to be more difficult than anticipated.
In an attempt to identify factors affecting centre recruit-
ment, the trial office engaged in regular discussions with
local teams and a number of issues were highlighted.
Fewer eligible women than anticipated
Many centres reported that fewer eligible women were
coming through their clinics than originally anticipated.
As part of the process of recruiting centres to the trial,
data on patient throughput was requested in order to as-
sess if sufficient women could be recruited to make the
centre viable. Lasagna’s Law suggests the incidence of the
disease studied in trials falls to 10% of the original estimate
when recruitment begins due to over-estimations before
recruitment starts [11]. Discussions with recruiting gynae-
cologists and local researchers suggested this may have
been the case in some of the POPPY trial centres. For ex-
ample, a centre which had over 3,000 new gynaecology
outpatients the year prior to the grant application being
submitted and expected to randomise three women per
month actually randomised three women in total over a
20-month recruitment period. The ability to set up more
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was therefore vital.
Patient preference for pelvic floor muscle training
Despite the lack of evidence for its effectiveness, some
physiotherapists are already offering individualised PFMT
for women who have small prolapses or are not good can-
didates for surgery [12]. Because the trial intervention was
available outside the trial, some women withdrew once they
discovered they had been allocated to the control group.
Whilst it could be argued that these women should not
have consented to participate as they were not in equipoise,
this was difficult to ascertain at the time of recruitment and
highlights the importance of exploring patient treatment
preferences at the point of recruitment. Work carried out
by Mills et al. (2011) [13] found discussion of treatment
preferences at the point of recruitment did not act as a bar-
rier to recruitment as expected, but allowed participants to
highlight their concerns and make an informed decision
that often included participation in the RCT.
Lack of support staff
In centres that did not have a local researcher, screening
was carried out by the recruiting gynaecologist, thus in-
creasing the burden on a busy clinician. This may have
had an impact on their ability to recruit.
Variations in approval systems
The process of securing PCT RM&G turned out to be a
lengthy process, with each RM&G department requiring
different information.
Variations between Scottish and English GP referral
procedures also affected the ability to involve GPs. At
the time of recruiting, in Scotland a new software system
called the SCI Gateway system [14] was introduced. This
is a national system that integrates primary and second-
ary systems enabling GPs to make referrals electronic-
ally. At the time, individual health boards were using the
system differently in that some wanted referrals sent
electronically to a generic location which would then be
dealt with by the health board, whilst others had individ-
ual clinicians named on the system so referrals could be
made directly. This posed a major problem for recruit-
ment. If a recruiting gynaecologist was not named on
the system, GPs could not refer to him or her directly.
In England, the Choose and Book system was in place
[15], a service that allows patients to choose which hospital
or clinic they wish to attend following a GP appointment.
As a result, the ability to refer potential participants to spe-
cific recruiting gynaecologists was outside the GP’s control.
Staff turnover
Potential participants were recruited from gynaecology
outpatient clinics. High staff turnover at these clinics dueto staff rotation of gynaecology registrars had an impact on
recruitment. The rotation resulted in continual training of
new registrars of the trial protocol and processes, which
impacted on our already limited time to recruit.
Collaborator incentives
Sustaining motivation of collaborating centres to con-
tinue recruiting and of participants to stay committed to
the trial can be a problem, particularly when the period
of involvement is lengthy. Few studies report on incen-
tives aimed at those individuals recruiting the trial par-
ticipants [2]. To compensate the healthcare professionals
for their time we paid a nominal amount of £55 for every
woman randomised to the trial. These funds could be
accessed by everyone involved in the trial at the recruit-
ing centre to support future professional development
such as attending courses and conferences. Whilst collab-
orating clinicians appeared enthused to receive this pay-
ment it did not appear to have a major impact on the
level of recruitment, echoing the work carried out by
Byrant and Powell [16].
Individualised monthly recruitment targets were intro-
duced for each recruiting centre in April 2009, 11 months
before recruitment stopped. Importantly, these targets
were realistic as they were based on previous recruitment
rates for the particular centre, and thus reflected the local
demographics. If centres met their targets, in addition to
receiving the £55 per woman randomised, they were sent
a £5 voucher to purchase refreshments such as coffee and
biscuits for the local team. Interestingly, this approach ap-
peared to have a more positive impact on recruitment at
some centres than the £55 per woman randomised. Whilst
only five centres met their recruitment targets every
month, recruitment overall improved, and centres that had
not recruited any women began to do so. Local researchers
reported that the recruiting staff appeared to be more en-
thused by this incentive. A possible reason for this could
be the staff most heavily involved in the research received
the benefits of this incentive immediately, supporting
Fletcher et al.’s [5] finding that all staff should be rewarded
for participation in research, not just medical staff. Also, in
some centres, the £55 per woman randomised did not
reach the local team members as it was absorbed by the
Research and Development departments. All research team
members at each recruiting centre also received a trial
mug and pen with the POPPY logo to heighten awareness
of the trial (Figure 2).
Communication
Overcoming trial fatigue experienced by both collaborators
and participants requires endurance and commitment
from everyone involved in a trial. Maintaining contact with
centre staff and participants played an important role in
the success of the POPPY trial. As POPPY was a national
Figure 2 Overall monthly recruitment figures.
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tact were by e-mail and telephone. Regular feedback and
updates from the trial office were sent to recruiting staff
and participants to ensure they felt involved. These took
the form of monthly email alerts to all centre staff de-
tailing individualised recruitment updates and continually
highlighting the importance of the trial, encouraging them
to continue recruitment and acknowledging the invest-
ment of time and support they had contributed to date.
They were also used to address any issues that arose re-
garding the trial processes and to provide updates on any
protocol amendments.
Discussion
Recruitment difficulties were encountered early on in
the POPPY trial and additional funds and time were
needed to extend both the recruitment period and the
number of recruiting centres. Even with these additional
resources, the target sample size of 520 was not achieved.
We employed a number of strategies to try and improve
recruitment and retention to the trial, and were guided in
choice of strategies by the experience of the Project Man-
agement Group and Clinical Trial Unit, and the advice of
the Trial Steering Committee, which had both clinician
and consumer representation. Some were more suc-
cessful than others, and they also differed in the resources
required.
It is important for trialists to recognise that over-
estimation of the number of potential participants avail-
able to take part in a trial is common. This must be
taken into account when deciding how many centres will
be required to deliver the chosen sample size. The im-
pact of delays in centre start-up on recruitment should
also be taken into account.
Minimising the impact of the trial processes on staff
time at collaborating centres is important. We found cen-
tres with a dedicated local researcher who assisted both in
recruitment and interacting with the trial office, re-
cruited more successfully. Good communication within the
whole research team (trial management team, collaboratingcentre staff and participants) and expression of appreciation
at every opportunity is vital. As their participation is en-
tirely voluntary, recognition and gratitude to participants as
well as centre staff are essential.
Changing the recruitment process once a trial is under
way results in the need for additional Ethical and Research
and Development approvals. Even with standardised sys-
tems in place to streamline some of these processes, delays
still occur, which affect the success of implementing the
new strategies within the constrained timescale. It is there-
fore necessary to try and use strategies that are likely to be
successful and which do not make excessive use of scarce
resources for their implementation, hence the importance
for trialists to report on their experiences of clinical trial
recruitment. A notable example in this trial was the deci-
sion to encourage recruitment by involving GP practices
from across health boards and health authorities in the
different countries, which led to significant work for the
trial office for little return. To our knowledge, no women
were referred to a recruiting gynaecologist in Scotland or
England following consultation with their GP for consider-
ation of the POPPY trial. This approach may have been
more successful if introduced at the start of the trial allow-
ing more time for approvals to be obtained and more GPs
to be informed about the trial.
We employed various centre staff and participant in-
centives, some of which appeared to be more successful
than others. In our trial, friendly communication with
participants by telephone appeared to have a positive
impact on the return of baseline paperwork, attendance
rates for 6-month prolapse assessments and the return
of 6-month questionnaires. However, women’s involve-
ment in the trial was still in the early stages at this point
and they may have been eager to attend their 6-month
review in any case, to see if there had been any change
in their prolapse and seek further treatment, if appropri-
ate. For recruiting centres, incentives whereby the staff
benefited immediately, such as the £5 voucher to pur-
chase refreshments, appeared to have a better impact on
staff morale and recruitment rates than a contribution
to departmental funds to be accessed at a later date for
professional development needs. Trialists should there-
fore ensure a budget for small, appropriate incentives is
included in grant applications, whenever possible.
In this narrative paper we have reported on our experi-
ences of recruiting participants from a gynaecology setting
and the different methods used in an attempt to improve
recruitment and trial implementation. We acknowledge
the limitations of narrative reflective articles and the im-
portance of incorporating more systematic approaches to
examining and addressing recruitment difficulties (for
example, [2]), including the use of qualitative research
[17] and the involvement of patient and public groups
where possible. Using these methods in the feasibility
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main trial resulting in a more efficient trial. Whilst we
did not test the methods discussed by formal RCT,
some were clearly too time consuming or unproductive to
be useful whilst others appeared promising such as incen-
tives for staff.
Conclusions
Successful recruitment of participants to a trial is central
to its success and is dependants on the support and
commitment of the whole research team. Poor recruit-
ment can result in an underpowered study which may
result in clinically important effects being missed. In an
ideal world more time and resources would be assigned
to the recruitment of collaborating centres and partici-
pants. However, constraints of most publicly funded re-
search mean the amount of time to recruit is very limited.
It is therefore important to have a recruitment and reten-
tion plan in place at the start of the trial to maximise
recruitment.
Our article reflects on the methodological challenges of
recruiting to a multi-centre RCT in UK gynaecology out-
patient settings and the systems put in place in an attempt
to address them. Trialists have a responsibility to publish
their experiences of recruitment and lessons learned to im-
prove the evidence base on clinical trial recruitment in dif-
ferent clinical areas and guide future trials. In addition,
there is a need for future RCTs to evaluate, where possible,
the effect of strategies designed to improve recruitment
and retention.
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